The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Seres Therapeutics, Inc(NASDAQ:MCRB) 
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that ...
Website: http://www.serestherapeutics.com
Founded: 2010
Full Time Employees: 108
Sector: Healthcare
Industry: Biotechnology
Seres Therapeutics Days Payable Outstanding ttm (DPO)
Seres Therapeutics Days Receivable Outstanding ttm (DSO)
Seres Therapeutics Days Inventory Outstanding ttm (DIO)
Seres Therapeutics Op Cashflow Per Share ttm
Seres Therapeutics Free Cashflow Per Share ttm
Seres Therapeutics Cash Per Share ttm
Seres Therapeutics P/S ratio ttm
Seres Therapeutics (GAAP) P/E ratio ttm
Seres Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.